Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: ACN stock price vs EPAM: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at EPAM's multiple
Needs EPAM P/E.
Implied fair value · at ACN's multiple
Needs ACN P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Nine period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Accenture plc · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
EPAM SYSTEMS, INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
INTERNATIONAL BUSINESS MACHINES CORP
ACN vs IBM
COGNIZANT TECHNOLOGY SOLUTIONS CORP
ACN vs CTSH
DXC Technology Co
ACN vs DXC
Infosys Ltd
ACN vs INFY
MARSH & MCLENNAN COMPANIES, INC.
ACN vs MMC
ROBERT HALF INC.
ACN vs RHI
GRID DYNAMICS HOLDINGS, INC.
ACN vs GDYN
Endava plc
ACN vs DAVA
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe ACN's superior margin profile and scale will continue to justify a higher multiple than EPAM, then ACN looks buyable here because its P/E is lower than EPAM's while the valuation framework still points to 15.0% upside.
ACN trades at a discount to EPAM-implied valuation framework despite superior profitability and scale. The current price of $165.92 sits below the implied P/E value of $190.86, implying 15.0% upside, and it is also near the upper half of the historical band but still below the implied level.
Supporting Metrics
